Trending
Subscribe to receive our latest publications
Subscribe to the PIE Magazine Daily to have our top stories delivered directly to your inbox.
Khartis Raises $95M to Advance Oral Drug for Thyroid Eye Disease
The next take on a familiar TED target could come in a pill. Khartis Therapeutics (San Diego, United States) has raised $95 million to move its oral treatment for thyroid eye disease (TED) towards the clinic, with the company planning to begin its first clinical trial in the first quarter of 2027. Taking IGF-1R down...
Marhiel Garrote